» Articles » PMID: 18812399

14-3-3 Activation of DNA Binding of P53 by Enhancing Its Association into Tetramers

Overview
Specialty Biochemistry
Date 2008 Sep 25
PMID 18812399
Citations 62
Authors
Affiliations
Soon will be listed here.
Abstract

Activation of the tumour suppressor p53 on DNA damage involves post-translational modification by phosphorylation and acetylation. Phosphorylation of certain residues is critical for p53 stabilization and plays an important role in DNA-binding activity. The 14-3-3 family of proteins activates the DNA-binding affinity of p53 upon stress by binding to a site in its intrinsically disordered C-terminal domain containing a phosphorylated serine at 378. We have screened various p53 C-terminal phosphorylated peptides for binding to two different isoforms of 14-3-3, epsilon and gamma. We found that phosphorylation at either S366 or T387 caused even tighter binding to 14-3-3. We made by semi-synthesis a tetrameric construct comprised of the tetramerization plus C-terminal domains of p53 that was phosphorylated on S366, S378 and T387. It bound 10 times tighter than did the monomeric counterpart to dimeric 14-3-3. We showed indirectly from binding curves and directly from fluorescence-detection analytical ultracentrifugation that 14-3-3 enhanced the binding of sequence-specific DNA to p53 by causing p53 dimers to form tetramers at lower concentrations. If the in vitro data extrapolate to in vivo, then it is an attractive hypothesis that p53 activity may be subject to control by accessory proteins lowering its tetramer-dimer dissociation constant from its normal value of 120-150 nM.

Citing Articles

Fragment-Based Interrogation of the 14-3-3/TAZ Protein-Protein Interaction.

Andlovic B, Valenti D, Centorrino F, Picarazzi F, Hristeva S, Hiltmann M Biochemistry. 2024; 63(17):2196-2206.

PMID: 39172504 PMC: 11375770. DOI: 10.1021/acs.biochem.4c00248.


Interaction patterns of methoprene-tolerant and germ cell-expressed JH receptors suggest significant differences in their functioning.

Kolonko-Adamska M, Zawadzka-Kazimierczuk A, Bartosinska-Marzec P, Kozminski W, Popowicz G, Krezel A Front Mol Biosci. 2023; 10:1215550.

PMID: 37654797 PMC: 10465699. DOI: 10.3389/fmolb.2023.1215550.


Sting and p53 DNA repair pathways are compromised in Alzheimer's disease.

Nelson T, Xu Y Sci Rep. 2023; 13(1):8304.

PMID: 37221295 PMC: 10206146. DOI: 10.1038/s41598-023-35533-6.


The Four Homeostasis Knights: In Balance upon Post-Translational Modifications.

Pieroni S, Castelli M, Piobbico D, Ferracchiato S, Scopetti D, Di-Iacovo N Int J Mol Sci. 2022; 23(22).

PMID: 36430960 PMC: 9696182. DOI: 10.3390/ijms232214480.


The p53 and Calcium Regulated Actin Rearrangement in Model Cells.

Hencz A, Szabo-Meleg E, Dayo M, Bilibani A, Barko S, Nyitrai M Int J Mol Sci. 2022; 23(16).

PMID: 36012344 PMC: 9408879. DOI: 10.3390/ijms23169078.


References
1.
Rittinger K, Budman J, Xu J, Volinia S, Cantley L, Smerdon S . Structural analysis of 14-3-3 phosphopeptide complexes identifies a dual role for the nuclear export signal of 14-3-3 in ligand binding. Mol Cell. 1999; 4(2):153-66. DOI: 10.1016/s1097-2765(00)80363-9. View

2.
Unger T, Juven-Gershon T, Moallem E, Berger M, Sionov R, Lozano G . Critical role for Ser20 of human p53 in the negative regulation of p53 by Mdm2. EMBO J. 1999; 18(7):1805-14. PMC: 1171266. DOI: 10.1093/emboj/18.7.1805. View

3.
Ou Y, Chung P, Sun T, Shieh S . p53 C-terminal phosphorylation by CHK1 and CHK2 participates in the regulation of DNA-damage-induced C-terminal acetylation. Mol Biol Cell. 2005; 16(4):1684-95. PMC: 1073652. DOI: 10.1091/mbc.e04-08-0689. View

4.
Friedler A, Veprintsev D, Freund S, von Glos K, Fersht A . Modulation of binding of DNA to the C-terminal domain of p53 by acetylation. Structure. 2005; 13(4):629-36. DOI: 10.1016/j.str.2005.01.020. View

5.
Ang H, Joerger A, Mayer S, Fersht A . Effects of common cancer mutations on stability and DNA binding of full-length p53 compared with isolated core domains. J Biol Chem. 2006; 281(31):21934-21941. DOI: 10.1074/jbc.M604209200. View